Similar findings were reported around the same time by Hoeflich et al. [26], who provided additional in vivo evidence that dual MEK-PI3K inhibition was synergistic in reducing tumour growth in a MDA-MB-231 derived xenograft model of TNBC. Here, PIK3CB is linked to neoplasm.